The new Solvency II framework gives insurers a series of choices and challenges. Those who see it as an opportunity, rather than a regulatory burden, will benefit from the change, says Jermund Ramsfjell of EMB Nordic.
How will the new Solvency II framework
directive, published in July, affect your company?
This is the question being asked by
insurers all over Europe, and they are coming
to very different conclusions. Everyone agrees,
though, that there will be winners and losers.
And, of course, we all know which of these
two outcomes is preferable.
The directive is a long, technical document,
but it gives companies a clear choice: to adopt
the standard formula approach where individual
risks are considered on their own and then
aggregated; or to opt for internal capital modelling,
which gives firms a true understanding
of the risks they carry. The first approach is
easier in the short run, whilst the second is
widely agreed to carry much greater business
benefits.
Many commentators have said that Solvency
II will give competitive advantage to the
largest firms at the expense of the rest, but
there is actually a more fundamental differentiator.
The real winners will be companies -
small or large - that really understand their
risks, and there is a simple reason for this. The
better you understand them the more efficiently
you can deal with them. For example,
you can maximise the value of your reinsurance
programme.
So much for the theory, but what does all
this mean in practice? Fortunately, we do not
have to look very far to see for ourselves. In
the UK, the FSA (Financial Services Authority)
has been practising risk-based regulation,
with internal capital models for all but the
smallest companies, since 2004. It is widely
recognised, even by those insurance executives
who initially opposed the idea, to havebrought greater professionalism and improved
use of capital right across the market.
The ICAS (Individual Capital Assessment Standards)
lies at the heart of the FSA regime. It requires
insurers to demonstrate that they have understood
the risks inherent in their businesses and
have taken the steps necessary to address
them. The risks involved go well beyond
underwriting, incorporating operational and
investment risk, among others.
Although it is up to companies to decide
how best to achieve these objectives, they
have nearly all decided to produce internal
capital models. These models enable you to
test any number of possible real-life scenarios,
measuring their potential financial impact
on the company.
As well as being an excellent way to assess
financial stability, these models have all kinds
of far-reaching business benefits, including
greater transparency, more capital-efficient
reinsurance buying and better investment
strategy. In fact, they have become essential
management tools, helping firms to make
decisions on wide-ranging strategic questions,
such as what classes of business to write. They
have stimulated big improvements in management
standards and professionalism. Risk
management, technical competence and business
processes have all advanced significantly.
The ICAS regime is enforced through socalled
"Arrow" visits by the FSA. These are
basically a means of checking that risk management
is being applied effectively right
across the organisation. Although capital
models are usually an essential component,
on their own they can never guarantee good
risk management. The FSA wish to be assured
that risk management is embedded in the
company. For example, do all senior staff
understand the process of risk management
and their roles in delivering it?
Although the details will inevitably differ,
Solvency II is based on the same principles as
the FSA's regime, with one important qualification.
As I explained at the start of the article,
Solvency II gives companies a choice. They
can, if they wish, opt out of this beneficial
process and choose the "standard formula"
instead. This allows companies to evaluate
risks separately, without having to understand
how they relate to each other.
The big fear is that smaller companies will
take this route because it appears to be easier
in the short run. If they do, they will lose out
to their competitors and may well have to pay
additional capital loadings to compensate for
their reduced understanding of risk. The
European Commission themselves make the
point that internal models remain a desirable
goal.
In fact, models are much easier than many
people realise. They can actually be easier for
smaller companies, because they are less complex
organisations. The best approach is to
start with a limited, well-defined project and
then build on it once you have understood
how it works. Many companies in the UK
found that the money these models saved on
the first year's reinsurance purchase alone
more than paid for the start-up costs.2
There is one question that firms often ask:
when is the best time to start creating and
implementing these models? And the simple
answer is, now. The deadline for Solvency II
may have been put back two years to 2012, but
there is a good reason for that. There is a lot of work involved, and companies will need the extra time in order to get it right.
There is an even better reason, though, for
starting work on these models. They will help
you to run your business, to make better
strategic decisions, to use your capital more
effectively. That is why it is also very important
to make the right choice when implementing
Solvency II.
Jermund Ramsfjell is a director at independent non-life actuaries EMB Nordic.